Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tacrolimus and Mycophenolate Versus Tacrolimus and Sirolimus vs. Neoral and Sirolimus Used in Combination in Cadaver and Non-HLA Identical Living Related Kidney Transplants
Brief Summary: Comparison of outcomes/safety/and tolerability of SRL/FK/Pred vs. FK/MMF/Pred vs. SRL/Neoral®/Pred in cadaveric and non-HLA identical LRD kidney transplants.


Options:
A: Arm Label: Low-dose Everolimus Group; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Cyclosporine A (CsA), Drug: Basiliximab, Drug: Corticosteroids | Arm Label: High-dose Everolimus Group; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Cyclosporine A (CsA), Drug: Basiliximab, Drug: Corticosteroids | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mycophenolic Acid (MPA), Drug: Cyclosporine A (CsA), Drug: Basiliximab, Drug: Corticosteroids | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): High-dose Everolimus Group, Low-dose Everolimus Group | Intervention Type: DRUG; Name: Mycophenolic Acid (MPA); Assigned to Arm(s): Control Group | Intervention Type: DRUG; Name: Cyclosporine A (CsA); Assigned to Arm(s): Control Group, High-dose Everolimus Group, Low-dose Everolimus Group | Intervention Type: DRUG; Name: Basiliximab; Assigned to Arm(s): Control Group, High-dose Everolimus Group, Low-dose Everolimus Group | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): Control Group, High-dose Everolimus Group, Low-dose Everolimus Group
B: Arm Label: Thymoglobulin and everolimus; Type: EXPERIMENTAL; Interventions: Drug: Thymoglobulin, Drug: Everolimus, Drug: Tacrolimus | Arm Label: Basiliximabe and everolimus; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Basiliximabe, Drug: Tacrolimus | Arm Label: Basiliximabe and mycophenolate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Basiliximabe, Drug: mycophenolate sodium, Drug: Tacrolimus | Intervention Type: DRUG; Name: Thymoglobulin; Assigned to Arm(s): Thymoglobulin and everolimus | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Basiliximabe and everolimus, Thymoglobulin and everolimus | Intervention Type: DRUG; Name: Basiliximabe; Assigned to Arm(s): Basiliximabe and everolimus, Basiliximabe and mycophenolate | Intervention Type: DRUG; Name: mycophenolate sodium; Assigned to Arm(s): Basiliximabe and mycophenolate | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): Thymoglobulin and everolimus | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): Basiliximabe and everolimus | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): Basiliximabe and mycophenolate
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Tacrolimus/Sirolimus | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Tacrolimus/MMF | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: Neoral/Sirolimus | Intervention Type: DRUG; Name: Tacrolimus/Sirolimus; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Tacrolimus/MMF; Assigned to Arm(s): B | Intervention Type: DRUG; Name: Neoral/Sirolimus; Assigned to Arm(s): C
D: Arm Label: TAC+MPA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus, Drug: Enteric Coated Mycophenolate Sodium (EC-MPS), Drug: Mycophenolate mofetil (MMF), Drug: Corticosteroids, Drug: Simulect | Arm Label: TAC+Certican; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Tacrolimus, Drug: Corticosteroids, Drug: Simulect | Arm Label: CycA+Certican; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Cyclosporin A, Drug: Corticosteroids, Drug: Simulect | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): CycA+Certican, TAC+Certican | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): TAC+Certican, TAC+MPA | Intervention Type: DRUG; Name: Cyclosporin A; Assigned to Arm(s): CycA+Certican | Intervention Type: DRUG; Name: Enteric Coated Mycophenolate Sodium (EC-MPS); Assigned to Arm(s): TAC+MPA | Intervention Type: DRUG; Name: Mycophenolate mofetil (MMF); Assigned to Arm(s): TAC+MPA | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): CycA+Certican, TAC+Certican, TAC+MPA | Intervention Type: DRUG; Name: Simulect; Assigned to Arm(s): CycA+Certican, TAC+Certican, TAC+MPA

Answer: C